Anpep is increased in breast cancer effusions [43], and its down regulation is associated with invasive colorectal cancer [30] and prostate cancer [31], while over expression of Anpep has been linked to Barrett’s adenocarcinomas [32]. Here, ANPEP is linked to Barrett adenocarcinoma.